Suppr超能文献

血清非结合胆汁酸升高检测到的进行性系统性硬化症的肠道受累情况。

Intestinal involvement in progressive systemic sclerosis detected by increased unconjugated serum bile acids.

作者信息

Stellaard F, Sauerbruch T, Luderschmidt C H, Leisner B, Paumgartner G

出版信息

Gut. 1987 Apr;28(4):446-50. doi: 10.1136/gut.28.4.446.

Abstract

In patients with progressive systemic sclerosis, impaired motor function of the small intestine may lead to bacterial overgrowth causing diarrhoea, steatorrhoea and malabsorption. As unconjugated serum bile acids have been proposed as markers for small bowel bacterial overgrowth, we studied individual unconjugated serum bile acids in 36 patients with progressive systemic sclerosis. These patients had significantly higher serum concentrations of unconjugated cholic acid (median 0.18; range 0.05-30.75 v 0.09; 0.01-0.19 mumol/l, p less than 0.001) and chenodeoxycholic acid (0.10; 0.01-6.83 v 0.04; 0.01-0.39 mumol/l, p less than 0.025) than healthy controls (n = 16). This difference was mainly due to patients with diarrhoea (n = 10), who had significantly higher concentrations of unconjugated serum bile acids than patients with normal bowel habit (cholic acid median 0.55 v 0.16 mumol/l, p less than 0.001; chenodeoxycholic acid 0.75 v 0.07 mumol/l; p less than 0.005). All patients with raised unconjugated serum bile acids had oesophageal motility disorders. These results confirm a relationship between motility disorders and bacterial overgrowth in patients with progressive systemic sclerosis.

摘要

在进行性系统性硬化症患者中,小肠运动功能受损可能导致细菌过度生长,进而引起腹泻、脂肪泻和吸收不良。由于游离型血清胆汁酸被认为是小肠细菌过度生长的标志物,我们对36例进行性系统性硬化症患者的个体游离型血清胆汁酸进行了研究。这些患者的游离型胆酸血清浓度(中位数0.18;范围0.05 - 30.75,而健康对照者为0.09;0.01 - 0.19 μmol/L,p < 0.001)和鹅去氧胆酸血清浓度(0.10;0.01 - 6.83,而健康对照者为0.04;0.01 - 0.39 μmol/L,p < 0.025)显著高于健康对照者(n = 16)。这种差异主要归因于腹泻患者(n = 10),他们的游离型血清胆汁酸浓度显著高于排便习惯正常的患者(胆酸中位数0.55对0.16 μmol/L,p < 0.001;鹅去氧胆酸0.75对0.07 μmol/L;p < 0.005)。所有游离型血清胆汁酸升高的患者均有食管运动障碍。这些结果证实了进行性系统性硬化症患者中运动障碍与细菌过度生长之间的关系。

相似文献

6
Gastrointestinal function in patients with progressive systemic sclerosis.
Clin Rheumatol. 1985 Dec;4(4):441-8. doi: 10.1007/BF02031897.
10
[Changes in upper gastrointestinal motility during scleroderma].
Medicina (Firenze). 1990 Jul-Sep;10(3):251-5.

引用本文的文献

2
Intestinal Involvement in Systemic Sclerosis: A Clinical Review.系统性硬化症的肠道累及:临床综述。
Dig Dis Sci. 2018 Apr;63(4):834-844. doi: 10.1007/s10620-018-4977-8. Epub 2018 Feb 21.
3
Gastrointestinal manifestations of systemic sclerosis.系统性硬化症的胃肠道表现
Dig Dis Sci. 2008 May;53(5):1163-74. doi: 10.1007/s10620-007-0018-8. Epub 2007 Oct 13.
7
Effect of oral gold salt therapy on bile acid absorption in rheumatoid arthritis patients.
Clin Rheumatol. 1990 Mar;9(1):42-7. doi: 10.1007/BF02030239.

本文引用的文献

6
Esophageal function after sclerotherapy of bleeding varices.出血性静脉曲张硬化治疗后的食管功能
Scand J Gastroenterol. 1982 Sep;17(6):745-51. doi: 10.3109/00365528209181088.
8
Scleroderma esophagus: a nonspecific entity.硬皮病食管:一种非特异性疾病。
Ann Intern Med. 1984 Jun;100(6):848-50. doi: 10.7326/0003-4819-100-6-848.
10
Serum bile acid analysis.血清胆汁酸分析。
Clin Chim Acta. 1983 Jan 7;127(1):1-17. doi: 10.1016/0009-8981(83)90070-0.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验